WebDuoResp®, Spiromax®, Fobumix Easyhaler® and Symbicort® Tubohale r containin budesonide/formoterol. There are 2 strengths of DuoResp® Spiromax and Fobumix Easyhaler® 160/4.5, and 320/9 ,These are equivalent to Symbicort 200/6 and Symbicort 400/12 respectively. Although equivalent the inhaler devices are significantly different. WebCost Fobumix Easyhaler 80/4.5 Budesonide/ formoterol Yes 1 dose bd Or 2 doses od + 1 dose prn No more than 6 doses on any single occasion Normally not more than 8 doses / day Max 12 doses / day for limited period 18 years and older DPI £21.50 / 30 days (based on 4 doses / day) Fobumix Easyhaler 160/4.5 Budesonide/ formoterol Yes 1 dose bd Or
3.0 Respiratory
WebFobumix Easyhaler is an inhaler used to treat adults of over 18 years and older who suffer from asthma. It works by reducing inflammation and swelling in lungs. It also relaxes the muscles of air passageways and prevents asthma symptoms like shortness of breath, coughing and wheezing. WebMar 21, 2024 · Fobumix Easyhaler 320/9 is an inhaler containing your medicine. The inhalation powder is white to yellowish in colour. Each inhaler contains 60 doses and has a white body with red upper part. Fobumix Easyhaler 320/9 is available in packs of 1 or 3 inhaler(s). Not all pack sizes may be marketed. Your pack may contain a protective cover. biology organisation topic
Appendix 3B Preferred Asthma Inhaler Devices for Adults 2024
WebAs Salbulin Novolizer is rarely used in the UK, we modelled an alternative scenario in which we changed MDIs to Salbutamol Easyhaler, whereby costs rose £3.01M for every 10% of inhalers changed. LABA: when switching to Formoterol Easyhaler savings of £1.02M were made for every 10% of MDIs changed. For proportional replacement, costs increased ... WebInhaled budesonide is a medicine used for asthma and chronic obstructive pulmonary disease (COPD). You can take it using an inhaler (sometimes called a "puffer"), which is usually brown or beige. This is called a "preventer" inhaler because it helps to prevent you from getting symptoms. WebEven then this cost is small in comparison to the £20-60 of many combination inhalers, while having a 10-30x smaller carbon footprint and dwarfed by savings from optimising care, reducing SABA overuse, consultations and treatment for exacerbations and hospitalisations. biology organisation topic test